/cloudfront-us-east-2.images.arcpublishing.com/reuters/PXRJ7EVHIJODFCX54OZZ2Q2C5A.jpg "CVS Health to drag decongestants with phenylephrine off cabinets")
[ad_1]
An individual walks by a CVS pharmacy retailer in Manhattan, New York, U.S., November 15, 2021. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights
Oct 19 (Reuters) – U.S. pharmacy chain CVS Health (CVS.N) mentioned on Thursday it’s pulling a number of the commonest decongestants with phenylephrine as the one lively ingredient from its cabinets and can not promote them.
The transfer comes after a panel of advisers to U.S. well being regulators raised doubts over the efficacy of the ingredient.
Last month, the panel refused to again the effectiveness of oral over-the-counter (OTC) medicines made with phenylephrine, including that no extra trials have been required to show in any other case.
CVS mentioned “other oral cough and cold products will continue to be offered to meet consumer needs.”
Phenylephrine was substituted for pseudoephedrine in lots of non-prescription chilly and allergy medicines after the latter was restricted amid experiences of abuse.
Phenylephrine is a significant part utilized in a few of standard merchandise like Benadryl, GSK’s (GSK.L) Advil and Kenvue’s (KVUE.N) Tylenol.
Reporting by Khushi Mandowara in Bengaluru; Editing by Shailesh Kuber
Our Standards: The Thomson Reuters Trust Principles.
[adinserter block=”4″]
[ad_2]
Source link